pectenotoxin 6: isolated from scallops (Patinopecten yessoensis); structure in first source
ID Source | ID |
---|---|
PubMed CID | 6442453 |
CHEBI ID | 189780 |
MeSH ID | M0295053 |
Synonym |
---|
pectenotoxin 6 |
(2r,5r,7r,8e,10e,12r,14s,16r,19r,20s,27s,28s,29r,32r,33r,35r)-14-[(2s,3r,4r)-2,3-dihydroxy-4-methyloxan-2-yl]-28-hydroxy-5,7,9,19,29-pentamethyl-18,31-dioxo-13,17,38,39,40,41,42,43-octaoxaoctacyclo[31.4.1.11,35.12,5.120,24.124,27.129,32.012,16]tritetracon |
124760-17-4 |
pectenotoxin 7 |
CHEBI:189780 |
124843-18-1 |
pectenotoxin 1, 18-carboxy-18-de(hydroxymethyl)- |
DTXSID701018108 |
Excerpt | Reference | Relevance |
---|---|---|
" In this report, we present results of in vitro toxicological assessment of pectenotoxin-6, a derivative of the parental toxin pectenotoxin-2 first isolated from toxic scallops." | ( Characterization of F-actin depolymerization as a major toxic event induced by pectenotoxin-6 in neuroblastoma cells. Alfonso, A; Botana, LM; Cabado, AG; Leira, F; Malaguti, C; Roman, Y; Rossini, GP; Vieytes, MR; Yasumoto, T, 2002) | 0.31 |
Role | Description |
---|---|
marine metabolite | Any metabolite produced during a metabolic reaction in marine macro- and microorganisms. |
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Class | Description |
---|---|
polycyclic ether | |
spiroketal | A cyclic ketal in which the ketal carbon is the only common atom of two rings. |
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (20.00) | 18.2507 |
2000's | 6 (60.00) | 29.6817 |
2010's | 2 (20.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (11.98) All Compounds (24.57) |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 11 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |